MedTrace Logo

Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair

NCT02604732 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-04-19

No results posted yet for this study

Summary

This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery.

Conditions

  • Inguinal Hernia

Interventions

PROCEDURE

Laparoscopic inguinal hernia repair with perioperative Aspirin

Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively

PROCEDURE

Laparoscopic inguinal hernia repair without perioperative Aspirin

Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Davide Lomanto, MD PhD · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2024-02-29
Completion
2024-05-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604732 on ClinicalTrials.gov